Birchview Capital’s BlossomHill Therapeutics BLSM Stock Holding History
Bought
Maintained
Sold
Other funds holding BLSM
Birchview Capital's BLSM Position: Q3 2026 in Review
Birchview Capital opened a new position in BlossomHill Therapeutics (BLSM) in Q3 2026: 50,000 shares worth $932K. The stake represents 0.54% of the portfolio and ranks #44 among its holdings.
39 funds tracked by Wall St. Rank hold BLSM as of Q3 2026.
- Birchview Capital held 50,000 shares of BlossomHill Therapeutics worth $932K as of Q3 2026.
- BlossomHill Therapeutics was a new Birchview Capital position in Q3 2026.
- BlossomHill Therapeutics made up 0.54% of Birchview Capital's portfolio in Q3 2026, its #44 holding.
- 39 funds tracked by Wall St. Rank held BlossomHill Therapeutics as of Q3 2026.
Based on Birchview Capital's 13F filing for Q3 2026, filed 13 Nov 2026.